Clinical Trial Update: Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Colorectal Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of S-8184 as second-line treatment for stage III/IV colorectal cancer (colorectal adenocarcinoma) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• S-8184

Snippet

Sponsor: Achieve Life Sciences | Conditions: Colorectal Adenocarcinoma | Phase 2 | Status: COMPLETED